Total Payments
$390.34
2024 Payments
$116.95
Companies
14
Transactions
25
Medicare Patients
957
Medicare Billing
$52,426
Payment Breakdown by Category
Food & Beverage$390.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $390.34 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $70.60 | 4 | $0 (2021) |
| Novo Nordisk Inc | $44.46 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.07 | 3 | $0 (2022) |
| ITI, Inc. | $33.40 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $30.20 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $28.90 | 2 | $0 (2024) |
| Lundbeck LLC | $26.59 | 2 | $0 (2022) |
| Boston Scientific Corporation | $25.83 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $17.48 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.95 | 7 | Esperion Therapeutics, Inc. ($28.90) |
| 2023 | $45.10 | 3 | Merck Sharp & Dohme LLC ($16.34) |
| 2022 | $93.81 | 6 | ITI, Inc. ($19.64) |
| 2021 | $134.48 | 9 | AbbVie Inc. ($70.60) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Rare Disease | ||||||
| 06/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.83 | General |
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CNS | ||||||
| 04/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/25/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Obesity | ||||||
| 06/08/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: DIABETES | ||||||
| 02/10/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2021 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Oral Contraceptive | ||||||
| 11/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: DIABETES | ||||||
| 10/28/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: DIABETES | ||||||
| 08/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 07/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 226 | 373 | $54,954 | $15,616 |
| 2022 | 7 | 183 | 305 | $43,400 | $11,838 |
| 2021 | 11 | 296 | 421 | $41,369 | $12,217 |
| 2020 | 8 | 252 | 462 | $53,070 | $12,755 |
Total Patients
957
Total Services
1,561
Medicare Billing
$52,426
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 105 | $28,620 | $7,445 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 28 | $9,968 | $2,582 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 53 | $10,335 | $2,541 | 24.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,430 | $1,347 | 94.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 96 | $1,056 | $806.40 | 76.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,029 | $532.56 | 51.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 36 | $2,340 | $327.60 | 14.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 16 | $176.00 | $35.20 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 93 | $24,645 | $6,385 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 48 | $9,360 | $2,135 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,628 | $1,498 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 13 | $988.65 | $913.25 | 92.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $686.00 | $346.36 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 32 | $2,080 | $288.10 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 50 | 92 | $1,012 | $272.16 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 78 | $20,670 | $5,684 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 57 | $10,891 | $2,582 | 23.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 25 | 25 | $1,901 | $1,661 | 87.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 16 | 16 | $784.00 | $379.04 | 48.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $1,225 | $359.25 | 29.3% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 14 | 14 | $686.00 | $331.66 | 48.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 23 | 23 | $1,127 | $330.51 | 29.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 20 | 20 | $980.00 | $315.67 | 32.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 57 | 99 | $1,089 | $297.00 | 27.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 31 | $2,015 | $276.79 | 13.7% |
About Melissa Erdmann, FNP
Melissa Erdmann, FNP is a Nurse Practitioner healthcare provider based in Fargo, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992727481.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Erdmann, FNP has received a total of $390.34 in payments from pharmaceutical and medical device companies, with $116.95 received in 2024. These payments were reported across 25 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($390.34).
As a Medicare-enrolled provider, Erdmann has provided services to 957 Medicare beneficiaries, totaling 1,561 services with total Medicare billing of $52,426. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner, Family
- Location Fargo, ND
- Active Since 07/24/2006
- Last Updated 05/11/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992727481
Products in Payments
- UBRELVY (Drug) $57.11
- CAPLYTA (Drug) $50.75
- REXULTI (Drug) $41.59
- JARDIANCE (Drug) $41.07
- BELSOMRA (Drug) $30.20
- NEXLETOL (Drug) $28.90
- Saxenda (Drug) $19.09
- STRENSIQ (Biological) $17.48
- ZENPEP (Drug) $14.32
- Wegovy (Drug) $14.05
- VRAYLAR (Drug) $13.49
- ARISTADA (Drug) $13.34
- SLYND (Drug) $11.80
- Ozempic (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fargo
Emily Greenstein, Aprn, Agnp-C, APRN, AGNP-C
Nurse Practitioner — Payments: $240,738
Nurse Practitioner $240,738
Sarah Matcha, Rn, Cnp, RN, CNP
Nurse Practitioner — Payments: $16,429
Nurse Practitioner $16,429
Mrs. Andrea Hanson
Nurse Practitioner — Payments: $2,890
Nurse Practitioner $2,890
Richard Schue, Np, NP
Nurse Practitioner — Payments: $1,861
Nurse Practitioner $1,861
Aaron Lindstrom, Np, NP
Nurse Practitioner — Payments: $1,850
Nurse Practitioner $1,850
Haley Fisher, Dnp, DNP
Nurse Practitioner — Payments: $1,427
Nurse Practitioner $1,427